Urologic Oncology: Seminars and Original Investigations

Aims & Scope

Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology.

The journal publishes practical, timely, and relevant clinical and basic science research articles which address any aspect of urologic oncology.

Each issue comprises original research, news and topics, survey articles providing short commentaries on other important articles in the urologic oncology literature, and reviews including an in-depth Seminar examining a specific clinical dilemma.

The journal periodically publishes supplement issues devoted to areas of current interest to the urologic oncology community.

Articles published are of interest to researchers and the clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.3
2024	2.40

Journal Citation Indicator

Year	Value
2024	2216

SJR (SCImago Journal Rank)

Year	Value
2024	0.855

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	89

Journal Rank

Year	Value
2024	6159

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Nanoparticles for drug delivery in cancer treatment

  Citation: 571

  Authors: Barbara, Eugene

• Micro-RNA profiling in kidney and bladder cancers

  Citation: 475

  Authors: Fedra, Chang Gong, Manuela, George A., Matteo, Pierfrancesco, Cinzia, Dolores, Massimo, Francesco, Leonard G., Carlo M., Raffaele

• A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

  Citation: 469

  Authors: Merle, Kai, Hartmut, Alfred C., Ingo, Dieter, Jens M., Georg

• Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

  Citation: 453

  Authors: George L., Cara, Mary Lou, Paul F.

• New frontiers in nanotechnology for cancer treatment

  Citation: 248

  Authors: Frank, June-Wha, Jerome P., Aleksandar F., Robert, Omid C.

• Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer

  Citation: 225

  Authors: Faysal A., Fadi, Jordan, Armen G., Simon, Wassim

• Incidence trends in primary malignant penile cancer

  Citation: 222

  Authors: Jill S., John L., Julio, Anna R.

• Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer

  Citation: 215

  Authors: Deborah W., Nita W., Dennis B., Patty L., Tsang L., Lawrence T.

• Clinical application of a 3D ultrasound-guided prostate biopsy system

  Citation: 196

  Authors: Shyam, Leonard S., Daniel J.A., Jiaoti, Maria Luz, Patricia, Aaron

• Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer☆

  Citation: 195

  Authors: Fadi N., Brian J., Michael A.

---